Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
54.50
-0.50 (-0.91%)
Mar 26, 2026, 1:30 PM CST
TPEX:4747 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,050 | 1,070 | 1,088 | 168.47 | 202.23 |
Short-Term Investments | 102.3 | - | - | - | - |
Cash & Short-Term Investments | 1,152 | 1,070 | 1,088 | 168.47 | 202.23 |
Cash Growth | 7.64% | -1.61% | 545.58% | -16.70% | -31.60% |
Accounts Receivable | 114.56 | 119.17 | 124.74 | 115.37 | 91.64 |
Other Receivables | 1.02 | 1.14 | 1.68 | 0.92 | 0.97 |
Receivables | 115.59 | 120.31 | 126.42 | 116.29 | 92.61 |
Inventory | 188.47 | 140.9 | 138.81 | 127.03 | 146.48 |
Prepaid Expenses | 0.65 | 3.11 | 4.68 | 2.18 | 4.56 |
Other Current Assets | 0.85 | 2.45 | 1.26 | 0.57 | 0.62 |
Total Current Assets | 1,457 | 1,337 | 1,359 | 414.53 | 446.49 |
Property, Plant & Equipment | 606.75 | 599.23 | 605.59 | 592.17 | 382.72 |
Long-Term Investments | 15.75 | 14.01 | 15.77 | 15.38 | 15.41 |
Other Intangible Assets | - | 1.41 | 2.83 | 4.24 | 5.66 |
Long-Term Deferred Tax Assets | 3.13 | 2.64 | 2.96 | 2.96 | 3.14 |
Other Long-Term Assets | 10.83 | 11.15 | 7.03 | 9.94 | 173.72 |
Total Assets | 2,094 | 1,965 | 1,993 | 1,039 | 1,027 |
Accounts Payable | 58.61 | 39.96 | 67.82 | 33.32 | 34.99 |
Short-Term Debt | 200 | 60 | 60 | 60 | 80 |
Current Portion of Long-Term Debt | 62.42 | - | - | - | - |
Current Income Taxes Payable | 0.17 | 11.37 | 21.43 | 16.47 | 13.24 |
Current Unearned Revenue | 6.15 | 7.86 | 7.35 | 7.06 | 8.39 |
Other Current Liabilities | 56.85 | 51.95 | 63.41 | 50.72 | 42.3 |
Total Current Liabilities | 384.21 | 171.14 | 220.01 | 167.56 | 178.91 |
Long-Term Debt | - | 90.22 | 100.83 | - | - |
Other Long-Term Liabilities | 0.16 | - | 0.15 | - | - |
Total Liabilities | 384.37 | 261.36 | 320.99 | 167.56 | 178.91 |
Common Stock | 453.81 | 449.32 | 436.68 | 300.19 | 300.19 |
Additional Paid-In Capital | 1,074 | 1,049 | 1,038 | 400.86 | 400.86 |
Retained Earnings | 190.37 | 217.49 | 196.32 | 180.85 | 157.4 |
Comprehensive Income & Other | -9.06 | -11.61 | 0.68 | -10.24 | -10.21 |
Shareholders' Equity | 1,709 | 1,704 | 1,672 | 871.66 | 848.24 |
Total Liabilities & Equity | 2,094 | 1,965 | 1,993 | 1,039 | 1,027 |
Total Debt | 262.42 | 150.22 | 160.83 | 60 | 80 |
Net Cash (Debt) | 889.4 | 919.84 | 926.78 | 108.47 | 122.23 |
Net Cash Growth | -3.31% | -0.75% | 754.40% | -11.26% | -26.22% |
Net Cash Per Share | 19.78 | 19.76 | 24.40 | 3.61 | 4.06 |
Filing Date Shares Outstanding | 45.03 | 44.93 | 43.67 | 30.02 | 30.02 |
Total Common Shares Outstanding | 45.03 | 44.93 | 43.67 | 30.02 | 30.02 |
Working Capital | 1,073 | 1,166 | 1,139 | 246.96 | 267.58 |
Book Value Per Share | 37.97 | 37.92 | 38.29 | 29.04 | 28.26 |
Tangible Book Value | 1,709 | 1,702 | 1,669 | 867.41 | 842.58 |
Tangible Book Value Per Share | 37.97 | 37.89 | 38.22 | 28.90 | 28.07 |
Land | - | 431.69 | 431.69 | 431.69 | 265.1 |
Buildings | - | 94.98 | 93.64 | 90.23 | 89.32 |
Machinery | - | 282.6 | 262.63 | 251.35 | 186.43 |
Construction In Progress | - | 7.02 | 19.82 | 4.45 | 16.66 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.